en · de · es
creatine-notes.peptides3081.com › Blog › Semaglutide Structure And Receptor Mechanism — Deep Dive

Semaglutide Structure And Receptor Mechanism — Deep Dive

By Editorial Desk · published 2026-02-20 · last reviewed 2026-03-13 · Blog

If you have been reading about albumin binding and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2026-03-13. Numbers and descriptions here follow the published literature rather than marketing material.

Semaglutide Structure and Receptor Mechanism

Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.

Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.

Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.

结构特征与受体作用机制

该分子作为 GLP-1 受体的选择性激动剂发挥作用,受体属于 B 类 G 蛋白偶联受体家族,激活后经 Gs 通路提升细胞内环腺苷酸水平。在胰腺 β 细胞,信号促进葡萄糖依赖性的胰岛素释放,血糖偏低时该作用明显减弱。在胰岛 α 细胞,胰高血糖素分泌受到抑制。中枢神经系统与胃肠道同样存在受体表达,相应信号参与食欲调节以及胃排空速率的降低。

皮下注射后吸收相对缓慢,绝对生物利用度约为百分之八十九,血药浓度峰值通常出现在给药后一到三天。与白蛋白结合使清除减慢,终末半衰期约为一百六十五小时,接近一周。连续给药约四到五周后达到稳态暴露水平。表观分布容积约为每千克零点二五升,血浆蛋白结合率超过百分之九十九。代谢以蛋白水解切割和脂肪二酸侧链的 β-氧化为主,相关产物主要经尿液与粪便排出。

序列层面的改动同时解决了两个问题,即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟,主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库,使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发,属于该类药物化学改造的典型范式。

Semaglutide at a glance

PropertyValueNotes
Molecular formulaC187H291N45O59free base, without counter-ion
Molecular weightAbout 4114 Dapeptide backbone plus attached lipid chain
Plasma half-lifeAbout 165 hourssupports once-weekly dosing in humans
Plasma protein bindingGreater than 99 percentattributed mainly to serum albumin
Receptor targetGLP-1 receptorGs-coupled, raises intracellular cyclic AMP

Background and Molecular Profile

Reported molecular weight is approximately 4113.6 daltons for the free base, and the peptide is supplied as a lyophilized powder or in buffered liquid form depending on the intended use. It is freely soluble in water when formulated with appropriate excipients, though the unconjugated peptide shows limited stability at neutral pH over long periods. Analytical characterization typically relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Purity specifications for research-grade material commonly exceed ninety-five percent by area. Isotopic and impurity profiles differ between suppliers.

Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.

The distinction between established facts and open questions matters here. That the peptide binds the GLP-1 receptor and stimulates insulin release in a glucose-dependent manner is well documented. How individual variability in receptor density, gastric emptying rate, and gut microbiome composition shapes response remains an active research area. Long-term outcomes beyond five years of continuous use are not yet fully characterized in published trials, and several extension studies are ongoing.

Related pages on this site

Background and Mechanism of Action

Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.

Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.

Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.

Handling, Storage, and Characterization

Reverse-phase high-performance liquid chromatography is the standard method for purity assessment, separating the peptide from truncated or oxidized variants. Mass spectrometry confirms molecular mass and detects modifications, while ultraviolet absorbance near 280 nanometers supports concentration measurement through tryptophan and tyrosine residues. Circular dichroism can indicate secondary structure, though the peptide is largely helical in solution, and ion-exchange chromatography resolves charge variants. Purity values above 95 percent are typical for research-grade material. Stability studies track degradation over time under defined conditions.

Lyophilized semaglutide is typically stored at temperatures between minus 20 and minus 80 degrees Celsius for long-term preservation. Short-term storage at 2 to 8 degrees Celsius is common for working aliquots. Repeated freeze-thaw cycles can degrade the peptide and are usually avoided. The molecule is hygroscopic in its solid form, so containers should remain sealed with desiccant. Solutions are less stable than powders and are generally prepared fresh. Light exposure is limited because aromatic residues can undergo photo-oxidation.

Notes from published material

The steam ejector is a popular form of pump for vacuum distillation and freeze-drying. A jet of steam entrains the vapour that must be removed from the vacuum chamber. Steam ejectors can have single or multiple stages, with and without condensers in between the stages. While both steam ejectors and diffusion pumps use jets of vapor to entrain gas, they work on fundamentally different principles - steam ejectors rely on viscous flow and mixing to pump gas, whereas diffusion pumps use molecular diffusion. This has several consequences. In diffusion pumps, the inlet pressure can be much lower than the static pressure of jet, whereas in steam ejectors the two pressures are about the same. Also, diffusion pumps are capable of much higher compression ratios, and cannot discharge directly to atmosphere.

In the late 17th century, the Shroud was placed in the chapel designed for that purpose by architect Guarino Guarini and attached to both the cathedral and the Royal Palace of Turin. It remained there until 1993, when it was moved into the cathedral. Repairs were made to the Shroud in 1694 by Sebastian Valfrè, improving upon the earlier patching by the Poor Clares. Further repairs were made in 1868 by Princess Maria Clotilde of Savoy. The Shroud was first photographed in 1898, during a public exhibition. The Shroud remained the property of the House of Savoy until 1983, when it was bequeathed to the Holy See according to the terms of the will of the former king Umberto II of Italy. A fire, possibly caused by arson, threatened the Shroud on 11 April 1997. In 2002 the Holy See had the Shroud restored. The cloth backing and thirty patches were removed, making it possible to photograph and scan the reverse side of the cloth, which had been hidden from view. A faint part-image of the body was found on the back of the Shroud in 2004. The Shroud was placed back on public display (the 18th time in its history) in Turin from 10 April to 23 May 2010; and according to Church officials, more than 2 million visitors came to see it. On Holy Saturday (30 March) 2013, images of the Shroud were streamed on various websites as well as on television for the first time in 40 years.

The menu was expanded to introduce various items such as crust flavors and 11 new specialty pizzas, and the company's employee uniforms were redesigned. In 2017, Pizza Hut was listed by UK-based company Richtopia at number 24 in the list of 200 Most Influential Brands in the World. By 2018, the chain was no longer the biggest in the United States, having been surpassed by Domino's. On June 25, 2019, Pizza Hut announced it was bringing back the logo and the red roof design that was used from 1976 until 1999. On August 7, 2019, Pizza Hut announced its intention to close about 500 of its 7,496 dine-in restaurants in the US, by the middle of 2021. On August 18, 2020, Pizza Hut announced it would be closing up to 300 restaurants after the bankruptcy of NPC International, one of its largest franchisees. In March 2021, Flynn Restaurant Group acquired NPC's 937 Pizza Hut locations. In 2025, Yum Brands closed 130 Pizza Hut locations. Citing the chain's continuing low sales, Yum Brands announced a strategic review of the chain's operations. In February 2026, it was announced that another 250 stores would close in the first half of 2026. In April 2026, it was reported that Yum was looking to sell the chain to private equity; that June, it was reported that the mainland China business was to be sold for $1.2 billion to Yum China Holdings, Inc., while the rest of the business was to be sold to LongRange Capital for $1.5 billion. The acquisition in China was completed on August 7, 2026, while the acquisition in the rest of the world was completed on September 1, 2026.

Sources: en.wikipedia.org

Background from the literature

Above all, we are in need of a renewed Enlightenment, which will base itself on the proposition that the proper study of mankind is man and woman [referencing Alexander Pope]. This Enlightenment will not need to depend, like its predecessors, on the heroic breakthroughs of a few gifted and exceptionally courageous people. It is within the compass of the average person. The study of literature and poetry, both for its own sake and for the eternal ethical questions with which it deals, can now easily depose the scrutiny of sacred texts that have been found to be corrupt and confected. The pursuit of unfettered scientific inquiry, and the availability of new findings to masses of people by electronic means, will revolutionize our concepts of research and development. Very importantly, the divorce between the sexual life and fear, and the sexual life and disease, and the sexual life and tyranny, can now at last be attempted, on the sole condition that we banish all religions from the discourse. And all this and more is, for the first time in our history, within the reach if not the grasp of everyone. Hitchens was accused of "anti-Catholic bigotry" by others, including Brent Bozell and UCLA Law Professor Stephen Bainbridge. When Joe Scarborough on 12 March 2004 asked Hitchens whether he was "consumed with hatred for conservative Catholics", Hitchens responded that he was not and that he just thinks that "all religious belief is sinister and infantile".

== Monitoring and improvement == Stewardship programs use laboratory utilization data to identify opportunities for improvement and evaluate interventions. Monitoring may include the appropriateness of test orders, retrieval of results, interpretation of results, test volumes, costs, and the effects of individual interventions. Broader measures of impact may include blood collection volumes, length of stay, readmission, morbidity, and mortality. Data-driven approaches can also use implementation science to identify behavioral and organizational factors that influence laboratory test use and to select interventions suited to those factors. Laboratory stewardship programs use multidisciplinary teams and laboratory utilization data to identify inappropriate testing and opportunities for improvement, implement interventions, and assess their effects. Programs can be organized differently depending on institutional priorities, available resources, and the clinical setting. Laboratory stewardship has also been discussed as a means of addressing health equity in laboratory testing.

A, B, C, D, E, F, G, I, J, K, L, P, Q1, R, S, T, U, V, Z1, Z2 Qi, Jianzhao; Wu, Jing; Kang, Shijie; Gao, Jingming; Hirokazu, Kawagishi; Liu, Hongwei; Liu, Chengwei (August 2024). "The chemical structures, biosynthesis, and biological activities of secondary metabolites from the culinary-medicinal mushrooms of the genus Hericium: a review". Chinese Journal of Natural Medicines. 22 (8): 676–698. doi:10.1016/S1875-5364(24)60590-X. ISSN 1875-5364. Retrieved 2026-01-30.

have disease progression during or following platinum-containing chemotherapy. have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy. On 16 February 2018, the Food and Drug Administration approved durvalumab for patients with unresectable stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.

Sources: en.wikipedia.org

Further detail

Internal waters: Waters landward of the baseline, over which the state has complete sovereignty: not even innocent passage is allowed without explicit permission from said state. Lakes and rivers are considered internal waters. Territorial sea: A state's territorial sea is a belt of coastal waters extending at most 22 kilometres from the baseline of a coastal state. If this overlaps with another state's territorial sea, the border is taken as the median line between the states' baselines, unless the states in question agree otherwise. A state can also choose to claim a smaller territorial sea. The territorial sea is regarded as the sovereign territory of the state. However, foreign ships (military and civilian) are allowed innocent passage through it, or transit passage for straits; this sovereignty also extends to the airspace over and seabed below. As a result of UNCLOS, states exercise a similar degree of control over their territorial sea as over land territory. They may thus utilise coast guard and naval patrols to enforce border control measures, provided they do not prevent innocent or transit passage. Contiguous zone: A state's contiguous zone is a band of water extending farther from the outer edge of the territorial sea to up to 44 kilometres (27 miles) from the baseline, within which a state can implement limited border control measures for the purpose of preventing or punishing "infringement of its customs, fiscal, immigration or sanitary laws and regulations within its territory or territorial sea".

=== Brick Structure Synthesis === A canonical DNA brick is a “32-nucleotide single strand with four 8-base binding domains (sticky ends)”. While each DNA brick has a distinct nucleotide sequence, they are all able to adopt the brick structure consisting of two 16-nucleotide antiparallel helixes joined by a single phosphate linkage. The two domains attached to the phosphate linkage are designated as “head” and “tail” domains. To bind two DNA bricks, a “head” domain will bind to a neighboring brick if their “tail” domain is the complementary strand of the earlier, and vice versa, producing a 90° dihedral angle. The concept of a Lego-like model is meant to depict the design in a simpler manner. Looking at a singular model in this manner, the two protruding round holes represent the two “tail” domains while recessed round holes represent the two “head” domains. Also, the brick can adopt a horizontal or vertical orientation. Using 3D modeling software such as LegoGen and Cadnano, it is possible to design DNA bricks by simply defining the target shape and subsequently the computer program can analyze it and automatically select the correct subset of bricks for self-assembly of the shape without having to manually design every DNA interaction.

== Education and career == Brodbelt has an undergraduate degree from the University of Virginia and earned her Ph.D. from Purdue University where she worked on gas phase ion chemistry using mass spectrometry. Following her Ph.D. she was a postdoc at the University of California, Santa Barbara before joining the University of Texas at Austin in 1989. As of 2016, she is the Roland Pettit Centennial Chair in the Department of Chemistry. She was the president of the American Society for Mass Spectrometry from 2014 to 2016.

They also noticed that the game "goes about fixing a lot of the niggling complaints we had about Episode One," applauding the open forests and rocky hills. The New York Times wrote that "while it sows a few seeds for the final episode of the trilogy, the game lacks the driving force of the previous episode". GameSpy felt that it was less consistent than its predecessors, and that the opening segments were "arguably the weakest".

For plant leaf wax, the relative humidity, the timing of leaf wax formation and the growth conditions including light levels affect the D/H fractionation of plant wax. From the Craig–Gordon model, it can be understood that leaf water in the growth chamber gasses is significantly D-enriched due to transpiration.

Sources: en.wikipedia.org

Frequently asked questions

How does semaglutide differ from native GLP-1?

Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.

Why does albumin binding matter for duration of action?

Albumin is the most abundant protein in plasma and carries molecules that bear fatty-acid chains. Binding shields the peptide from renal filtration and from peptidases, keeping a circulating reservoir. Slow release from this reservoir produces sustained receptor occupancy and supports infrequent dosing.

Is the insulin-releasing effect dependent on blood glucose?

The insulinotropic effect is glucose-dependent, meaning secretion increases mainly when glucose is elevated. This property is often described as lowering the chance of hypoglycaemia when the compound is used alone. Other glucose-lowering agents used at the same time can still cause low blood glucose.

Semaglutide 与天然 GLP-1 的主要差别是什么?

差别集中在三处:第 8 位残基被非天然氨基酸取代,第 34 位换成精氨酸,第 26 位增加一条脂肪酸侧链。前两处改动降低酶解速率,侧链则通过白蛋白结合延长循环时间。综合结果是半衰期从约两分钟延长到约一周。

Network